A carregar...
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
BACKGROUND: Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus warfarin according to age. METHODS AND RESULTS:...
Na minha lista:
Publicado no: | J Am Heart Assoc |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4889207/ https://ncbi.nlm.nih.gov/pubmed/27207971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003432 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|